Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Carrara, Verena I ^a   Phyo, Aung P ^a   Nwee, Paw ^a   Soe, Ma ^a   Htoo, Hsar ^a   Arunkamomkiri, Jaruwan ^a   Singhasivanon, Pratap ^b   Nosten, François ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; MEFLOQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ADULT; ARTICLE; AUDIOMETRY; AUDITORY SCREENING; AUDITORY THRESHOLD; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OTOTOXICITY; PATIENT ASSESSMENT; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDY; THAILAND; TYMPANOMETRY; ACOUSTIC IMPEDANCE; ADOLESCENT; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; MIDDLE AGED;

ACOUSTIC IMPEDANCE TESTS; ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; AUDIOMETRY; DRUG THERAPY, COMBINATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING LOSS; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; THAILAND;

EID: 57049151818     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-233     Document Type: Article

References (40)

1. Position of WHO's Roll Back Malaria Department on malaria treatment policy. http://www.who.int/malaria/docs/who_apt_position.htm
2. Mefloquine-its 20 years in the Thai Malaria Control Program. C Wongsrichanalai S Prajakwong SR Meshnick GD Shanks K Thimasarn, Southeast Asian J Trop Med Public Health 2004 35 300 308 15691128
3. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. F Nosten C Luxemburger F ter Kuile C Woodrow JP Eh T Chongsuphajaisiddhi NJ White, J Infect Dis 1994 170 971 977 7930743
4. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. F Nosten M van Vugt R Price C Luxemburger KL Thway A Brockman R McGready F ter Kuile S Looareesuwan NJ White, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185
5. Randomized, controlled dose-optimization studies of dihydroartemisinin- piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. EA Ashley S Krudsood L Phaiphun S Srivilairit R McGready W Leowattana R Hutagalung P Wilairatana A Brockman S Looareesuwan F Nosten NJ White, J Infect Dis 2004 190 1773 1782 10.1086/425015 15499533
6. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. R Price M van Vugt L Phaipun C Luxemburger J Simpson R McGready F ter Kuile A Kham T Chongsuphajaisiddhi NJ White F Nosten, Am J Trop Med Hyg 1999 60 547 555 10348227
7. Artesunate combinations for treatment of malaria: meta-analysis. M Adjuik A Babiker P Garner P Olliaro W Taylor N White, Lancet 2004 363 9 17 10.1016/S0140-6736(03)15162-8 14723987
8. Fatal neurotoxicity of arteether and artemether. TG Brewer SJ Grate JO Peggins PJ Weina JM Petras BS Levine MH Heiffer BG Schuster, Am J Trop Med Hyg 1994 51 251 259 7943542
9. Neurotoxicity in animals due to arteether and artemether. TG Brewer JO Peggins SJ Grate JM Petras BS Levine PJ Weina J Swearengen MH Heiffer BG Schuster, Trans R Soc Trop Med Hyg 1994 88 Suppl 1 S33 36 10.1016/0035-9203(94) 90469-3 8053022
10. Arteether: risks of two-week administration in Macaca mulatta. JM Petras DE Kyle M Gettayacamin GD Young RA Bauman HK Webster KD Corcoran JO Peggins MA Vane TG Brewer, Am J Trop Med Hyg 1997 56 390 396 9158046
11. Dose-dependent brainstem neuropathology following repeated arteether administration in rats. RF Genovese DB Newman Q Li JO Peggins TG Brewer, Brain Res Bull 1998 45 199 202 10.1016/S0361-9230(97)00339-0 9443840
12. Neuropathologic toxicity of artemisinin derivatives in a mouse model. A Nontprasert S Pukrittayakamee AM Dondorp R Clemens S Looareesuwan NJ White, Am J Trop Med Hyg 2002 67 423 429 12452498
13. Behavioral and neural toxicity of arteether in rats. RF Genovese DB Newman JM Petras TG Brewer, Pharmacol Biochem Behav 1998 60 449 458 10.1016/S0091-3057(98)00019-7 9632228
14. Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs. W Classen B Altmann P Gretener C Souppart P Skelton-Stroud G Krinke, Exp Toxicol Pathol 1999 51 507 516 10661809
15. Studies of the neurotoxicity of oral artemisinin derivatives in mice. A Nontprasert S Pukrittayakamee M Nosten-Bertrand S Vanijanonta NJ White, Am J Trop Med Hyg 2000 62 409 412 11037787
16. Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats. RF Genovese DB Newman TG Brewer, Pharmacol Biochem Behav 2000 67 37 44 10.1016/S0091-3057(00)00309-9 11113482
17. A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. M van Vugt BJ Angus RN Price C Mann JA Simpson C Poletto SE Htoo S Looareesuwan NJ White F Nosten, Am J Trop Med Hyg 2000 62 65 69 10761725
18. Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients. E Kissinger TT Hien NT Hung ND Nam NL Tuyen BV Dinh C Mann NH Phu PP Loc JA Simpson NJ White JJ Farrar, Am J Trop Med Hyg 2000 63 48 55 11357994
19. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. S Toovey A Jamieson, Trans R Soc Trop Med Hyg 2004 98 261 267 10.1016/j.trstmh.2003.11.001 15109547
20. A case-control auditory evaluation of patients treated with artemether-lumefantrine. R Hutagalung H Htoo P Nwee J Arunkamomkiri J Zwang VI Carrara E Ashley P Singhasivanon NJ White F Nosten, Am J Trop Med Hyg 2006 74 211 214 16474072
21. No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria. MB McCall AJ Beynon EA Mylanus AJ van der Ven RW Sauerwein, Trans R Soc Trop Med Hyg 2006 100 1098 1104 10.1016/j.trstmh.2006. 02.017 16808940
22. Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial. R Gurkov T Eshetu IB Miranda N Berens-Riha Y Mamo T Girma E Krause M Schmidt JM Hempel T Loscher, Malar J 2008 7 179 18796142 10.1186/1475-2875-7-179
23. Preferred method for clinical determination of pure-tone thresholds. R Carhart J Jerger, J Speech Hearing Disorders 1959 24 330 345
24. Comparison of ABR stimuli for the early detection of ototoxicity: conventional clicks compared with high frequency clicks and single frequency tonebursts. SA Fausti CL Flick AM Bobal RM Ellingson JA Henry CR Mitchell, J Am Acad Audiol 2003 14 239 250 12956307
25. Auditory brainstem response: Differential diagnosis. M Don B Kwong, Handbook of clinical audiology New York: Lippincott Williams & Wilkins, Katz J, 5 2002 274 297
26. Brain stem auditory evoked responses in human infants and adults. K Hecox R Galambos, Arch Otolaryngol 1974 99 30 33 4809084
27. Normative data in clinical ABR. L Bergholtz, Scand Audiol Suppl 1981 13 75 81 6944782
28. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. SEAQUAMAT, Lancet 2005 366 717 725 10.1016/S0140-6736(05) 67176-0 16125588
29. Neurotoxicity and efficacy of arteether related to its exposure times and exposure levels in rodents. QG Li SR Mog YZ Si DE Kyle M Gettayacamin WK Milhous, Am J Trop Med Hyg 2002 66 516 525 12201585
30. Dose-dependant brain stem neuropathology following repeated arteether administration in rats. RF Genovese DB Newman QG Li JO Peggins TG Brewer, Brain Res Bull 1998 45 199 202 10.1016/S0361-9230(97)00339-0 9443840
31. Effects of hyperthermia on the auditory-evoked brainstem responses in mice. B Katbamna AE Bankaitis DA Metz LE Fisher, Audiology 1993 32 344 355 10.3109/00206099309071865 8267525
32. Effect of hyperthermia on somatosensory evoked potentials in the anaesthetized rat. GD Panjwani MK Mustafa A Muhailan IS Aneja A Owunwanne, Electroencephalogr Clin Neurophysiol 1991 80 384 391 10.1016/0168-5597(91)90086- D 1716563
33. Effect of hyperthermia on brain auditory evoked potentials in the conscious sheep. KY Mustafa IS Aneja M Khogali A Nasreldin I Arar, Electroencephalogr Clin Neurophysiol 1988 71 133 141 10.1016/0168-5597(88)90071- 8 2449331
34. The influence of exercise-induced temperature elevations on the auditory brain-stem response (ABR). CJ Thomas JD Jones PD Scott ME Rosenberg, Clin Otolaryngol Allied Sci 1991 16 138 141 10.1111/j.1365-2273.1991.tb01962.x 2070528
35. [Effect of body temperature changes on evoked potentials]. H Tachibana M Takeda M Sugita J Kondo M Miyauchi A Matsuoka, Rinsho Byori 1990 38 1383 1386 2082039
36. Effect of tractor driving on hearing loss in farmers in India. A Kumar NN Mathur M Varghese D Mohan JK Singh P Mahajan, Am J Ind Med 2005 47 341 348 10.1002/ajim.20143 15776468
37. Hearing impairment among young Chinese in a rural area. I Morioka WZ Luo K Miyashita S Takeda YX Wang SC Li, Public Health 1996 110 293 297 10.1016/S0033-3506(96)80092-8 8885666
38. Effect of smoking on hearing loss: quality assessment and meta-analysis. K Nomura M Nakao T Morimoto, Prev Med 2005 40 138 144 10.1016/j.ypmed.2004.05. 011 15533522
39. [Findings of standard and high-frequency audiometry in workers exposed to occupational noise for long durations]. S Turkkahraman U Gok T Karlidag E Keles A Ozturk, Kulak Burun Bogaz Ihtis Derg 2003 10 137 142 12941983
40. Is there a relevant effect of noise and smoking on hearing? A population-based aging study. Y Uchida T Nakashimat F Ando N Niino H Shimokata, Int J Audiol 2005 44 86 91 10.1080/14992020500031256 15913156